冠状动脉亮度在心声成像上作为川崎病的新标记 - - 基于机器学习的集群分析
Daisuke Masui1, Satoru Iwashima2, Yoshifumi Miyagi3
1Department of Pediatrics, Hamamatsu University School of Medicine Shizuoka Japan.
Circulation reports
|February 11, 2026
概括
在Kawasaki病 (KD) 中,冠状动脉亮度 (CAB) 可以使用机器学习量化. 该方法可以识别具有明显冠状动脉特征的患者子组,并预测治疗耐药性.
科学领域:
- 心脏病学 心脏病学
- 医疗成像医学成像
- 机器学习 机器学习
背景情况:
- 冠状动脉亮度 (CAB) 在急性川崎病 (KD) 中观察到.
- 在KD中CAB的临床意义仍然不清楚.
- 这项研究量化了CAB并评估了其在急性KD中的临床相关性.
研究的目的:
- 在急性川崎病 (KD) 中量化冠状动脉亮度 (CAB).
- 用无监督机器学习 (ML) 来评估CAB的临床意义.
- 根据CAB对KD患者进行分层分组,并预测治疗结果.
主要方法:
- 分析了89名急性阶段KD患者的心声图像.
- 提取和标准化冠状动脉 (CA) 像素值作为Z分数.
- 应用K-平均集群到CA Z-分数来分层患者.
主要成果:
- 无监督的ML将KD患者分为两类,基于CAB.
- 集群1显示CA直径和Z-score显著增加.
- 在集群1中发现总 bilirubin 和 pentraxin 3 (IVIG 耐药性预测剂) 的较高水平.
结论:
- 使用ML的定量CAB分析有效地对KD患者进行了分层.
- 这种方法可以作为评估KD严重程度的新型非侵入性工具.
- 该方法显示了预测急性KD中静脉注射免疫球蛋白 (IVIG) 耐药性的潜力.
相关概念视频
Coronary Artery Disease I: Introduction
1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology
519
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care
302
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations
422
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures
734
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Peripheral Artery Disease I: Introduction
393
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
393


